Armand, P., Kuruvilla, J., Michot, J., Ribrag, V., Zinzani, P. L., Zhu, Y., . . . Moskowitz, C. H. (2020). KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure. Blood Adv.

Armand, Philippe, John Kuruvilla, Jean-Marie Michot, Vincent Ribrag, Pier Luigi Zinzani, Ying Zhu, Patricia Marinello, Akash Nahar, و Craig H. Moskowitz. "KEYNOTE-013 4-year Follow-up of Pembrolizumab in Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure." Blood Adv 2020.

Armand, Philippe, et al. "KEYNOTE-013 4-year Follow-up of Pembrolizumab in Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure." Blood Adv 2020.